Home  /  Resource Library  /  Clinical analysis of first-line treatment of 43 cases of chronic lymphocytic leukemia with fludarabine and cyclophosphamide combined with rituximab (FCR regimen)

Clinical analysis of first-line treatment of 43 cases of chronic lymphocytic leukemia with fludarabine and cyclophosphamide combined with rituximab (FCR regimen)

Study examined rituximab based chemoimmunotherapy for first line treatment of CLL.